This survey asks you to briefly reflect on the benefits of the A2S2 newsletters. Your feedback will help us improve future market intelligence projects.

A2S2 is a project financed by UNITAID to help support the production of artemisinin to ensure adequate supplies of ACTs (Artemisinin Based Combination Therapies) to meet forecasted malaria treatment requirements.

Question Title

* 1. Do you find the information in the newsletter useful?

Question Title

* 2. Have you used the information in the newsletter to inform any decisions in the last 12 months?

Question Title

* 3. Would you recommend this newsletter to someone else in your position?

Question Title

* 4. Please let us know what other information you would have found useful to receive in this newsletter format, and why (optional)

Question Title

* 5. What is your primary role in the artemisinin market? The organization you represent primarily:

T